Germinal center in Thailand. Pathology enthusiast. Horology, sometimes.

Joined April 2023
Advanced-stage high-grade B-cell #lymphoma (MYC-R with BCL2 and/or BCL6-R), single-centre series, n=124: 69 MYC/BCL2, 34 triple hit, 21 MYC/BCL6. Targeted NGS in 36. CR 44%, 2-year OS 59.8%, CNS relapse 10.1%. DA-R-EPOCH associated with better OS than R-CHOP-based therapy. MYC/BCL6-R: more CNS relapse and rapid progression to death after relapse, with a different cell of origin from BCL2-R disease. Perhaps a place for novel agents - definitely looking for more cohorts treated with bispecific antibodies 1L in the coming years. #lymsm doi.org/10.1182/bloodadvance…
12
1
45
2,761
Just a bread and butter case: with better control of HIV disease it is easy to forget about Kaposi sarcoma - this example with hyaline globules. (erythrophagolysosomes).
15
45
1,551
Centroblast retweeted
Appearances deceive: unmasking mantle cell lymphoma with prolymphocytic morphology ashpublications.org/blood/ar…
5
19
1,047
Recently shared this interesting case at our interesting case conference and now want to share it with you all :) Core needle biopsy of a well circumscribed lesion in a pre-menopausal female #breastpath #pathx #pathtwitter #pathresidents
7
24
67
4,081
🩺 Bread-and-butter daily cases series This prostate tumor clearly read the literature: voluminous cytoplasm, pyknotic nuclei, and a histiocytoid appearance. The adjacent benign glands show atrophic look with prominent basal cell hyperplasia. What happened to this prostate? #DxMindMap #ProstatePath #GUPath #PathTwitter @MGBpathology
1
8
31
1,391
This is another "Man in Istanbul" case 😉. Kidney carcinoid tumor. 👇 another rare and cute example. xitter.cf/Andres_Matoso/status/9… References: surgpath.theclinics.com/arti…. pubmed.ncbi.nlm.nih.gov/1789…
🧩 Kidney riddle An unusual growth pattern for kidney tumor. What kidney tumor would you consider for this bizarre architecture? #DxMindMap #KidneyPath #GUPath #PathTwitter @JHUpath @MGBpathology
4
24
772
Can we better predict outcomes for thyroid cancer patients with brain metastases? A new @thyroidjournal international multicenter study developed a disease-specific prognostic score and identified key factors linked to survival. ow.ly/w8QA50ZVwqj #ThyroidJournal
4
7
424
Renal biopsy in a middle-aged woman with a known history of NSCLC. Clinical query: primary renal tumor vs. metastasis? PAX8 shows weak nuclear expression 🧐 So, renal cell carcinoma or is there another diagnosis here? 🔬 #GUPath #PathTwitter
8
9
1
43
2,887
Histologic features favoring CMV hepatitis in liver allograft biopsies with overlapping rejection-type injury ➡️Microgranulomas ➡️Neutrophilic microabscesses Difficult topic, covered by IJSP. Read more here 👉🏼 tinyurl.com/5enfmwv3 #PathTwitter #GIPath #MedicalLiverPath
15
43
1,164
Where does an expert look first on a slide? The expert does not have better eyes, just a better sense of where to look first. In a 2024 randomized study, 53 students learned histology from the same expert video. Half also saw a live overlay of where the expert's eyes went. That group recognized patterns better afterwards (d = 0.40). When you teach at the microscope, say where you are looking, not only what you see.
2
10
357
New! This study from the @IASLC Pathology Working Group demonstrates that fixation protocol significantly impacts immunocytochemistry performance on non–cell block cytological preparations. 🔗: acsjournals.onlinelibrary.wi… @natasharekhtman @mdlozanoe #CytoPath #LungCancer
4
11
749
Metastatic lobular breast carcinoma (in bone marrow) or chameleon🦎 on a branch? 😬 Pathology 101: NEVER EVER let a BM M bx go without a keratin IHC in a pt with hx of lobular breast carcinoma. These tumors… keeping me humble & on my toes…😨 #hemepath
6
20
2
77
2,929
Hi all, Excited to share a recent study by @IASLC Pathology Committee that led to a long-awaited update in lung neuroendocrine tumor classification. Great joint effort by multiple institutions across continents! jto.org/article/S1556-0864(2…
2
41
2
104
6,707
ปวดหัวกับญาติ ไปรพ.เอกชนหมดไป 2 แสนกลับมาโวยวาย ๆ รักษาไม่หาย ไม่ดีขึ้น ไม่ได้วินิจฉัย เพราะอะไรอะทำไมอาการแบบนี้ ต้องไปที่ไหน ไปถามอาจารย์หมอให้หน่อยต้องกินยาอะไร ไปซื้อเองได้ไม่ง้อหรอก โทรไปก็บ่นร้อยแปดพันเก้า น้ำท่วมทุ่ง ดราม่า 80 เนื้อหา 20 นี่นั่งเปิดผลส่องกล้องดูก็เอ้า ตัดชิ้นเนื้อไปนิ มีวินิจฉัยแยกโรคนิ นี่ก็ถาม ๆ เค้าสงสัยโรคนี้นิ เค้าตัดชิ้นเนื้อไปด้วยนิ เค้าน่าจะอธิบายว่านั่นนี่โน่นนะ ญาติก็ เออ เค้าพูดแล้ว เค้าบอกแล้ว อ้ะลืมไปเลยนะเนี่ย 🫩 อ่อสรุปคือหมอคุยหมดทุกอย่างแล้ว คนตรวจก็อดีตอ.แพทย์รรพ.ด้วยอะ ละชั้นเป็นใครนะ รับบท GI med สาวหรอ advice ทับอ.อีกทีหรอ งง
4
529
11
346
71,435
Centroblast retweeted
Tiroiditis de Hashimoto, en The Lancet (2026). La causa más frecuente de hipotiroidismo. Puntos clave: 🔵 Anti-TPO positivo en 90%. Pero se miden una sola vez, no necesitas volver a hacerlo. Anti-Tg solo si anti-TPO es negativo. 🔵 Si es subclínico: tratar si TSH ≥10. Entre 4–10: individualizar (<65 años, síntomas claros, bocio o alto riesgo CV). COn TSH elevada + anticuerpos positivos progresan 5% por año a hipotiroidismo franco. 🔵 Dosis inicial de Levotiroxina: 1.4–1.8 µg/kg (menos en ancianos o cardiópatas), TSH a las 6–8 semanas; tras dos TSH normales separadas ≥3 meses, control anual. T4+T3 sin beneficio consistente. 🔵 Embarazo: eutiroidea anti-TPO+: sin tratamiento, solo vigilancia de TSH. Hipotiroidea conocida: meta de TSH de <2.5 antes de concebir y subir dosis 20–30% al confirmar embarazo. 🔵 Selenio baja anti-TPO a 6 meses, pero no mejora función, calidad de vida ni progresión, sin utilidad.
5
274
2
941
32,542
Centroblast retweeted
Dx? maxilla 2016-1p-24(etc.) #Pathkeys
1
2
16
952
Centroblast retweeted
one of my top 👿LN mets I hate🔬: ✔️hormone-treated prostatic adenoca (shown here; paired NKX3.1 #IHCpath) also on my💩list: 👎🏽MELF-pattern endometrial ca 👎🏽signet-ring adenoca (from anywhere!)
3
8
28
1,563
Brisk perivascular lymphocytic infiltration at the edge of a MMR-deficient, hypermutant #glioblastoma. Sometimes the hypermutant subset of #GBM triggers such a reaction. #pathology #neuropath #pathtwitter
4
25
93
2,541